Cancer syndromes and therapy by stop-codon readthrough. Trends in Molecular MedicineTrends Mol. Med., 18(11), 667 - 678.
(2012). Chitosan-based gene delivery vectors targeted to the peripheral nervous system. Journal of Biomedical Materials Research - Part AJ. Biomed. Mater. Res. Part A, 95(3 A), 801 - 810.
(2010). Chitosan/siRNA nanoparticles biofunctionalize nerve implants and enable neurite outgrowth. Nano LettersNano Lett., 10(10), 3933 - 3939.
(2010). Endothelialization of chitosan porous conduits via immobilization of a recombinant fibronectin fragment (rhFNIII7-10). Acta Biomaterialia, 9(3), 5643 - 5652.
(2013). Fibronectin-mediated endothelialisation of chitosan porous matrices. BiomaterialsBiomaterials, 30(29), 5465 - 5475.
(2009). Functionalization of poly(amidoamine) dendrimers with hydrophobic chains for improved gene delivery in mesenchymal stem cells. Journal of Controlled ReleaseJ. Control. Release, 144(1), 55 - 64.
(2010). Gene delivery into mesenchymal stem cells: A biomimetic approach using rgd nanoclusters based on poly(amidoamine) dendrimers. BiomacromoleculesBiomacromolecules, 12(2), 472 - 481.
(2011). Hyaluronic acid / chitosan multilayer coatings on neuronal implants for localized delivery of siRNA nanoplexes. Journal of Controlled Release, 168(3), 289 - 297.
(2013). Improving chitosan-mediated gene transfer by the introduction of intracellular buffering moieties into the chitosan backbone. Acta BiomaterialiaActa Biomater., 5(8), 2995 - 3006.
(2009). Modified-chitosan/siRNA nanoparticles downregulate cellular CDX2 expression and cross the gastric mucus barrier. PLoS ONE, 9(6).
(2014). Molecular recognition force spectroscopy: A new tool to tailor targeted nanoparticles. SmallSmall, 7(9), 1236 - 1241.
(2011). Neural cell growth on TiO 2 anatase nanostructured surfaces
. Thin Solid FilmsThin Solid Films, 518(1), 160 - 170.
(2009). Non-viral gene delivery to mesenchymal stem cells: Methods, strategies and application in bone tissue engineering and regeneration. Current Gene TherapyCurr. Gene Ther., 11(1), 46 - 57.
(2011). A novel nanoparticle delivery system for in vivo targeting of the sciatic nerve: Impact on regeneration. NanomedicineNanomedicine, 7(8), 1167 - 1180.
(2012). Osteogenic differentiation of mesenchymal stem cells using PAMAM dendrimers as gene delivery vectors. Journal of Controlled ReleaseJ. Control. Release, 134(2), 141 - 148.
(2009). (2014). Protein matrices for improved wound healing: Elastase inhibition by a synthetic peptide model. BiomacromoleculesBiomacromolecules, 11(9), 2213 - 2220.
(2010). Receptor-mediated gene delivery using PAMAM dendrimers conjugated with peptides recognized by mesenchymal stem cells. Molecular PharmaceuticsMol. Pharm., 7(3), 763 - 774.
(2010). Regenerative medicine for the treatment of spinal cord injury: More than just promises?. Journal of Cellular and Molecular MedicineJ. Cell. Mol. Med., 16(11), 2564 - 2582.
(2012). Rescue of wild-type E-cadherin expression from nonsense-mutated cancer cells by a suppressor-tRNA. European Journal of Human Genetics, 22(9), 1085 - 1092.
(2014). Scientists perception of ethical issues in nanomedicine: A case study. NanomedicineNanomedicine, 6(4), 681 - 691.
(2011). Taking tissue adhesives to the future: From traditional synthetic to new biomimetic approaches. Biomaterials Science, 1(3), 239 - 253.
(2013). Targeted gene delivery into peripheral sensorial neurons mediated by self-assembled vectors composed of poly(ethylene imine) and tetanus toxin fragment c. Journal of Controlled ReleaseJ. Control. Release, 143(3), 350 - 358.
(2010). Endothelialization of chitosan porous conduits via immobilization of a recombinant fibronectin fragment (rhFNIII 7-10)
. Acta BiomaterialiaActa Biomater.
(2012).